Relationship Between Plasma Fibrinogen and Coronary Heart Disease in Women
- 1 January 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 19 (1) , 67-72
Abstract
—Plasma fibrinogen is an independent risk factor for coronary heart disease (CHD) in men; however, its role in women is less clear. We examined the ability of plasma fibrinogen to predict CHD in a community-based, case-control study of women aged 65 years or younger living in the greater Stockholm area. Cases were all patients hospitalized for an acute coronary event between February 1991 and February 1994. Controls were randomly selected from the city census and were matched to cases by age and catchment area. Plasma fibrinogen was measured 3 to 6 months after hospitalization by using a fibrinogen assay based on fibrinogen polymerization time measurement. Of the 292 consecutive cases, 110 (37%) were hospitalized for an acute myocardial infarction and 182 (63%) for angina pectoris. The mean age±SD in both patients and controls was 56±7 years. Mean levels of plasma fibrinogen in patients and controls were 3.66±0.81 and 3.25±0.64 g/L ( P <0.0001), respectively. The age-adjusted odds ratio (OR) for CHD in the highest versus the lowest quartile of plasma fibrinogen was 6.0 (95% confidence interval [CI], 3.5 to 10.4). After adjustment for age, cigarette smoking, body mass index, systolic blood pressure, total cholesterol, high density lipoprotein cholesterol, triglycerides, and educational level, the OR was 3.0 (95% CI, 1.6 to 5.5). Further adjustment for C-reactive protein yielded the same result. In both premenopausal and postmenopausal women, the multivariate-adjusted ORs were 7.0 (95% CI, 1.8 to 28.3) and 2.1 (95% CI, 1.0 to 4.4), respectively. These results provide evidence that plasma fibrinogen is associated with an excess risk of CHD in women.Keywords
This publication has 16 references indexed in Scilit:
- Risk factors for cardiovascular disease in women: Assessment and managementEuropean Heart Journal, 1996
- Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and womenThe American Journal of Cardiology, 1996
- The contribution of thrombosis to the clinical expression of coronary atherosclerosisThrombosis Research, 1996
- Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina PectorisNew England Journal of Medicine, 1995
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiographyEuropean Heart Journal, 1993
- Hemostatic factors according to menopausal status and use of hormone replacement therapyAnnals of Epidemiology, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- PLASMA-FIBRINOGEN AND THROMBOEMBOLI AFTER MYOCARDIAL INFARCTIONThe Lancet, 1976
- A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test)Clinica Chimica Acta, 1963